Apolipoprotein E genotypes were measured in 83 patients with familial hypercholesterolaemia (FH) and in 175 blood donor controls. Following DNA extraction from peripheral blood, each sample was genotyped for the Apo E polymorphism by polymerase chain reaction. No significant differences were found in the levels of the E2 and E3 alleles between the two groups, while the 1:4 allele was approximately twice as prevalent in the FH patients as in controls (P=O'006, df= I). Of the FH patients, 8-4% were homozygous for the /;4 allele while this genotype was rare in controls (P=O'009, df= I). These results suggest that the 1:4 allele is over represented in the FH population and may contribute to increased cholesterol levels and consequent vascular disease.
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Familial hypercholesterolaemia (FH) is a common disorder of lipid metabolism which is characterized clinically by raised serum total and low-density lipoprotein (LDL) cholesterol levels, physical signs of hyperlipidaemia such as xanthomas and an increased risk of coronary artery disease. It has an autosomal dominant mode of inheritance with an estimated incidence of one in 500 in most Caucasian populations. It is caused by mutations in the gene coding for the low density lipoprotein receptor (LDLR).1 The clinical expression of FH is highly variable in terms of the degree of hypercholesterolaemia, age of onset, severity of coronary artery disease, response to dietary and drug lipid lowering therapy and is related to the type of LDLR mutation.? However the clinical expression is variable even amongst individuals with the same LDLR defect;' and is influenced by other genetic, environmental and lifestyle factors. Variation in LDL cholesterol levels has been shown to be modulated by the combined effect of a particular LDLR mutation and polymorphisms of the gene coding for apolipoprotein E. 4 Apolipoprotein E is a 229
Correspondence: Ms E B Duly. 534 amino acid protein which plays a central role in lipid metabolism by serving as a ligand for the binding of lipoproteins to lipoprotein receptors. Specific interaction between Apo E and the LDLR receptor is an essential mechanism controlling the removal of Apo E rich lipoproteins [very low-density lipoprotein (VLDL), chylomicrons and intermediate density lipoproteins] and thus determines the homeostasis of cholesterol and triglyceride.' The gene is polymorphic with three co-dominant alleles E2, 1:3 and E4 producing three apo E isoforms differing from each other by single amino acid substitutions. Apo E3 contains a single cysteine at residue 112 and an arginine at position 158; apo E2 contains cysteine residues at both positions 112 and 158; and apo E4 contains arginine residues at both positions. Numerous population studies have shown a relationship between apo E2 and E4 and serum lipid levels.v? The combination of either of these alleles with a particular LDLR mutation may influence the predisposition to coronary artery disease. A recent study has implicated E4 as a contributory factor in hyperlipidaemia and heart disease in mutation positive individuals within an FH family.' Thus we investigated the frequency of Apo E genotypes in FH probands attending a lipid clinic. 1~L_ _~L % showed the frequency of E4 to be significantly different in the FH and control groups X 2=7'51, df = I, P = 0·006. The genotypes in the two groups are shown in Fig. 2 , with 8A% of FH patients homozygous for the <.4 allele compared to 1·7% of controls. Chi-squared analysis of the frequency of the E44 genotype compared with all other genotypes E23, 33 and 34 gave the following results X 2 = 6·82, df= I, P = 0·009.
Our results show that the frequency of the E2 and E3 alleles was comparable between the FH group and controls. The E4 allele occurred at a frequency of 11·4% in the control group, which is slightly lower than the 14·3% quoted for Belfast in a previous apo E phenotyping study. II The r.4 allele was approximately twice as prevalent in the FH group (20.5%) as compared to controls and 8A% of the FH patients were homozygous for E4, whereas this genotype was rare in the control group (1'7%). Studies have shown that polymorphisms of apo E are a major determinant of inter-individual variation in the initiation and progression of atherosclerosis.F One recent study has found that the effect of the
MATERIALS AND METHODS

RESULTS
Patient samples
Patients (83) diagnosed with definite familial hypercholesterolaemia (FH) were recruited from the lipid clinic at the Royal Victoria Hospital. The median age of the FH group was 50·6 y (range 17-78 years); 51 patients were male, 31 female. The diagnostic criteria were those recommended by the Simon Broome Trust:" serum total cholesterol > 7·5 mmol/L or LDLcholesterol > 4·9 mrnol/L, showing autosomal dominant inheritance of hyperlipidaemia or coronary artery disease and the presence of xanthomas in the proband or a first degree relative. These were compared with 175 blood donor controls. The patient and control groups were caucasian and of Northern Irish origin. Blood samples were taken in EDTA and stored at 4"C. DNA was extracted within 3 days according to a protocol based on the guanidine-hydrocholoride method."
Polymerase chain reaction (PCR) Samples were analysed for apo E genotype according to the method of Hixson and Vernier."? Amplification of the target region was carried out by PCR. Each 50 ilL PCR reaction contained 15pmol of forward and reverse primers (F4 and F6), 6 nmol deoxynu-c1eotide triphosphates (dNTPs), 250 nmol MgCI 2 , 5% dimethyl sulphoxide and 1 unit Taq polymerase enzyme (Gibco, Bethesda Research Laboratories, USA). Each sample was overlaid with mineral oil prior to PCR with the following conditions: Initial denaturation at 94"C for 5 min, then 35 cycles of 94C for 30 s, 69"C for 30 sand n"c for 5 s. The final synthesis was at n"c for 5 mins.
Restriction enzyme digestion
The PCR products (10 ilL) were incubated with 10 units of Hha I (Gibco, Bethesda Research Laboratories, USA) at 37 uC overnight. The digest products were resolved by 8% polyacrylamide gel electrophoresis in a mini gel system. 16 The E4 allele may therefore be over-represented in the FH population and may, by increasing cholesterollevels, contribute to vascular disease. Given that all patients were recruited from lipid clinics and therefore clinically symptomatic, this over representation of E4 alleles may indicate a high risk genotype in conjunction with an LDLR gene mutation. The association between the LDLR and apo E genes cannot be explained in terms of linkage disequilibrium between the genes due to the physical distance between the two loci. A further study in a separate population group would be useful to confirm this association and the role of apo E in the severity and progression of FH.
